Perbak Capital Partners’s Accenture ACN Stock Holding History

Perbak Capital Partners’s Portfolio ACN Stock Details ACN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,293	Closed	-$4.02M	–	5
2026 Q1	$4.02M	Buy	+20,293	New	+$4.73M	0.99%	16

Other funds holding ACN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Perbak Capital Partners's ACN Position: Q2 2026 in Review

Perbak Capital Partners sold out of Accenture (ACN) in Q2 2026, closing a stake of 20,293 shares — an estimated $4.02M sold.

Perbak Capital Partners first reported a position in ACN in Q1 2026 and held it in 1 quarter. The position peaked at $4.02M in Q1 2026. 1,896 funds tracked by Wall St. Rank hold ACN as of Q2 2026.

Perbak Capital Partners reported no remaining Accenture position as of Q2 2026 after selling out during the quarter.
Perbak Capital Partners sold 20,293 Accenture shares in Q2 2026, an estimated $4.02M.
Perbak Capital Partners first reported a position in Accenture in Q1 2026 and held it in 1 quarter.
Perbak Capital Partners's Accenture position peaked at $4.02M in Q1 2026.
1,896 funds tracked by Wall St. Rank held Accenture as of Q2 2026.

Based on Perbak Capital Partners's 13F filing for Q2 2026.